Analyst
Goldman Sachs
Equibles does not estimate personal net worth.
Matt Delator is recorded as Analyst at Goldman Sachs. Matt Delator has spoken on 1 earnings call across 1 company, most recently for Elanco Animal Health Inc on November 6, 2026. The companies whose calls Matt Delator spoke on are classified in the Healthcare sector.
“Maybe just another on the outlook for 2027, you know, obviously, you're seeing strong momentum across, you know, key product launches, and you reiterated the long-term growth algorithm, but could you speak a little further about how we should think about the breakdown of that mid-single-digit top line between pet and…”
Goldman Sachs
Analyst
Transcript header (unverified)
Drug Manufacturers - Specialty & Generic · Healthcare
